Moneycontrol PRO
aarti drugs
Jump to
15 Results Found
  • Nifty may see selling pressure, support at 9520; 4 stocks to buy today: Prakash Gaba Jun 16, 2017 08:20 AM IST

    Nifty may see selling pressure, support at 9520; 4 stocks to buy today: Prakash Gaba

    Prakash Gaba of prakashgaba.com is of the view that crucial support for the Nifty is at 9580-9520 and the resistance is at 9700- 9724. "Aarti Drugs, AIA Engineering, Dewan Housing Finance and Capital First are bullish plays for the day," he adds.

  • Stocks in news: Wipro, Coal India, Tata Motors, Clariant, BILT Dec 02, 2016 08:01 AM IST

    Stocks in news: Wipro, Coal India, Tata Motors, Clariant, BILT

    L&T | Tata Power | Wipro | Coal India | Tata Motors | TVS Motor | Jindal Drilling | Shilpa Medicare | Clariant Chemicals | AstraZeneca | Reliance Communications | Crompton Greaves | Ballarpur Industries | JSPL | Bombay Dyeing and Advanced Enzymes are stocks, which are in the news today.

  • Top buzzing midcap stocks to trade on October 18 Oct 18, 2016 01:43 PM IST

    Top buzzing midcap stocks to trade on October 18

    Here are a few top buzzing midcap stocks picked up by CNBC-TV18's analysts in trade today. We have - Aurobindo Pharma, Arvind, Shriram EPC, PNB, ICICI Bank, Gujarat Pipavav, Zensar, Aarti Drugs, Aarti Industries, and Indian Hume.

  • RBI's on-tap bank licence guidelines to keep IIFL, SKS in focus May 06, 2016 08:14 AM IST

    RBI's on-tap bank licence guidelines to keep IIFL, SKS in focus

    Stocks likely to be in the news are: Shriram Transport Finance Corporation, SKS Microfinance, Equitas Holdings, LIC Housing Finance, IIFL Holdings, Reliance Capital, L&T Finance Holdings, Bajaj Finance, Hero Motocorp, Emami, Fortis Healthcare , ITC, Multi Commodity Exchange of India, Aarti Drugs, DHFL, Zee Entertainment Enterprises.

  • See double-digit growth next year if macros improve: Aarti Drugs Feb 08, 2016 11:13 AM IST

    See double-digit growth next year if macros improve: Aarti Drugs

    Adhish Patil, CFO, Aarti Drugs said the slowdown in sales for the third quarter was mainly due to decline in exports and some inventory losses.

  • Exports contribution to revenue may rise to 40%: Aarti Jun 16, 2015 03:15 PM IST

    Exports contribution to revenue may rise to 40%: Aarti

    Adhish Patil, CFO, Aarti Drugs, says the contribution of exports to revenue is likely to increase to 40 percent. The company got WHO good manufacturing practice (GMP) for the anti-diabetic drug in the first week of June.

  • Top buzzing midcap stocks to trade on March 24 Mar 24, 2015 01:29 PM IST

    Top buzzing midcap stocks to trade on March 24

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Monnet Power, Strides Arcolab, Shasun Pharma, NIIT Technologies, Tilaknagar Industries and Aarti Drugs.

  • Here are top 10 stocks to focus on March 24 Mar 24, 2015 08:48 AM IST

    Here are top 10 stocks to focus on March 24

    Here are top 10 stocks to focus on March 24 – HDFC, Wockhardt, Geometric, GMR Infra, Sun Pharma, Ranbaxy, Hero Moto, JSPL, Adani Power and Aarti Drugs.

  • Here are top 10 stocks to focus on March 18 Mar 18, 2015 09:00 AM IST

    Here are top 10 stocks to focus on March 18

    Here are top 10 stocks to focus on March 18 - IOC, Tech Mahindra, Sesa Sterlite, Reliance Infra, Mahindra & Mahindra, M&M Financial, Bhushan Steel, SBI, Gujarat Fluoro and Aarti Drugs

  • Here are six things that you need to know about Aarti Drugs Feb 16, 2015 05:11 PM IST

    Here are six things that you need to know about Aarti Drugs

    CNBC-TV18s Nigel D‘Souza tells you six things that you need to know about Aarti Drugs

  • Here's what Anand Rathi recommending to buy now Sep 10, 2014 05:59 PM IST

    Here's what Anand Rathi recommending to buy now

    With the focus of government trying to provide the education space a much wider audience, the space would be ahead of the curve, says Shirish Pardeshi.

  • Aarti Drugs can move to Rs 200: SP Tulsian Sep 04, 2012 10:36 AM IST

    Aarti Drugs can move to Rs 200: SP Tulsian

    Aarti Drugs can move to Rs 200 in the next 6 months, says SP Tulsian of sptulsian.com. Their Q1 earnings came well. They posted a topline of Rs 190 crore and EPS of Rs 7.90 for the quarter, while EPS for whole of FY12 was close to Rs 18 or maybe sub-Rs 18.

  • Tulsian's multibaggers:IL&FS Engineering, Aarti Drugs Sep 04, 2012 09:47 AM IST

    Tulsian's multibaggers:IL&FS Engineering, Aarti Drugs

    In an interview with CNBC-TV18 SP Tulsian of sptulsian.com picked IL&FS Engineering and Aarti Drugs as multibagger stocks. He is bullish on both the stocks and expects them to fetch better returns ahead.

  • Bulls Eye: Buy Finolex Cable, HUL, Infosys Jun 18, 2012 12:13 PM IST

    Bulls Eye: Buy Finolex Cable, HUL, Infosys

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Aarti Drugs expects over Rs 700cr revenue in FY12 Apr 13, 2011 04:38 PM IST

    Aarti Drugs expects over Rs 700cr revenue in FY12

    Harshit Savla, MD of Aarti Drugs, in an interview with CNBC-TV18’s Gautam Broker and Latha Venkatesh, spoke about the recent happenings in his company and the road ahead.

Sections
ISO 27001 - BSI Assurance Mark